SCHEMBL5199715

SCHEMBL5199715

CC(C)CCCN(CCCC(C)C)C([NH])=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.38
KDM4A O75164 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
BLM P54132 1/20 0.38
CA1 P00915 4/20 0.37
CA12 O43570 2/20 0.37
CA9 Q16790 2/20 0.37
CA2 P00918 1/20 0.37
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
ALDH1A1 P00352 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5198515 0.88 CA1 (0.41) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL2197366 0.82 CA1 (0.41) CA1CA12CA9CA2
SCHEMBL8682327 0.79 KDM4C (0.39) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL8682329 0.79 BLM (0.43) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL5199718 0.77 KDM4C (0.38) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL4903765 0.77 KDM4C (0.38) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL17710564 0.76 LMNA (0.36) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL5200028 0.75 CA1 (0.54) CA1CA12CA9CA2LMNA
SCHEMBL28582583 0.73 KDM4C (0.46) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL15238200 0.73 KDM4C (0.46) KDM4CKDM4APHF8KDM2ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 KDM4C 194/4885KDM4A 393/4885PHF8 744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.